AC Immune (ACIU) Retained Earnings (2015 - 2026)

AC Immune (ACIU) has 12 years of Retained Earnings data on file, last reported at -$578.3 billion in Q1 2026.

• On a quarterly basis, Retained Earnings fell 134524.84% year-over-year to -$578.3 billion in Q1 2026; TTM through Mar 2026 was -$578.3 billion, a 134524.84% decrease from a year earlier, with the FY2025 full-year figure at -$529.5 billion, down 125869.34% from the prior year.
• Retained Earnings for Q1 2026 stood at -$578.3 billion, down from -$549.3 billion in the prior quarter.
• Over the last five years, Retained Earnings for ACIU reached as high as -$251.6 million in Q3 2022 and fell as low as -$578.3 billion in Q1 2026.
• Historically, Retained Earnings has averaged -$115.6 billion across 5 years, with a median of -$420.4 million in 2024.
• Across the five-year window, Retained Earnings jumped 99.88% in 2024 and slumped 134524.84% in 2026, its largest moves.
• Year by year, Retained Earnings stood at -$274.1 million in 2022, then sank by 129971.79% to -$356.5 billion in 2023, then soared by 99.88% to -$420.4 million in 2024, then tumbled by 130573.5% to -$549.3 billion in 2025, then dropped by 5.28% to -$578.3 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$578.3 billion in Q1 2026, -$549.3 billion in Q4 2025, and -$524.7 million in Q3 2025.